ALISO VIEJO, Calif., April 23, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the underwriters of its initial public offering exercised their over-allotment option to purchase an additional 825,000 shares of its common stock at $8.00 per share. The option was granted in connection with the company's initial public offering of 5,500,000 shares on March 29, 2007. The company granted the underwriters an option to purchase up to an additional 825,000 shares to cover over-allotments. Banc of America Securities LLC and Citigroup Global Markets Inc. are the joint bookrunning managers for the offering. Cowen and Company, LLC and Canaccord Adams Inc. are co-managers.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on March 28, 2007. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the common stock of SenoRx, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Copies of the final prospectus may be obtained from the offices of Banc of America Securities LLC, Capital Markets (Prospectus Fulfillment) by e-mail to dg.prospectus_distribution@bofasecurities.com or by mail to Banc of America Securities LLC, Capital Markets Operations, 100 West 33rd Street, 3rd Floor, New York, NY 10001, Citigroup Global Markets Inc., 388 Greenwich Street, New York, NY 10013, Cowen and Company, LLC, 1221 Avenue of the Americas, 14th Floor, New York, NY 10020, and Canaccord Adams Inc., 101 Montgomery Street, Suite 2000, San Francisco, CA 94104.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605